ArticleTranslational psychiatry2025
Genetic and striatal structural connection linking behavioral inhibition/activation system to adolescent anxiety and depression.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Behavioral inhibition/activation system in obsessive-compulsive disorder: brain morphometric correlates and treatment outcomes.Translational psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Behavioral Inhibition and Activation Systems (BIS/BAS) are central to emotional regulation, yet their genetic and neural mechanisms remain unclear. In this study, we examined how polygenic risk for BIS/BAS relates to striatal structural connectivity and emotional vulnerability during adolescence-a critical period for affective problems onset. Using data from 1,929 adolescents (average age 9.95 years, 50.39% female) in the ABCD Study, we found that BIS and BAS polygenic risks exerted dissociable influences on striatal structural gradient (SSG), delineating distinct neurobiological pathways to anxiety and depression. Elevated BIS risk was linked to greater anxiety symptoms, whereas increased BAS risk related more strongly to depressive and withdrawn features. Altogether, our findings elucidate a neuroanatomical pleiotropy mechanism, whereby shared striatal connectivity architectures differentially channel genetic susceptibilities into distinct symptom dimensions, thereby advancing our understanding of the neural pathways underlying emotional vulnerability across diverse psychiatric phenotypes. (a) Construction of PRS. Variants associated with BIS and BAS were extracted from GWAS data. Effect weights were calculated, and a weighted sum was performed to derive the PRS scores, with detailed procedures outlined in the Methods section. (b) Framework for striatal structural connectopic mapping. Probabilistic tractography was conducted from the striatal volumetric seed region. The resulting connectivity matrix, denoted as A, was subjected to dimensionality reduction using Singular Value Decomposition (SVD), resulting in matrix B. Subsequently, the similarity matrix S was computed utilizing the η² Coefficient. The graph's Laplacian was then decomposed into its eigenvectors, which correspond to the connectopic maps of the seed region. (c) Simplified Schematic of a Multivariate Model Investigating Gene-Brain-Behavior Correlations. Green arrows indicate mediation pathways involving BIS PRS. Orange dashed arrows indicate mediation pathways involving BAS PRS. Grey arrows denote significant associations between variables without mediation. GWAS, Genome-Wide Association Study. PRS, Polygenic Risk Scores. BIS, Behavioral Inhibition System. BAS, Behavioral Activation System. BAS_rr, BAS Reward Responsiveness.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.